Sputnik V vaccine MOSCOW, Jan 15The Russian Direct Investment Fund (RDIF) has provided the World Health Organization with all the documentation on Sputnik V, said WHO representative in Russia Melita Vujnovic. «. As noted at the end of December, WHO Director of Regulation and Prequalification Rogerio Gaspar, the organization expects that all documents on Sputnik V will be sent by the end of January. The organization is ready to conduct an inspection at the vaccine production site in February 2022. According to Russian Deputy Foreign Minister Alexander Pankin, Moscow sees encouraging signals in the issue of WHO recognition of the Russian drug, but regards them rather as calming Russia.
Murashko announced changes in the recommendations for the treatment of the omicron strain «Sputnik V» is approved in 71 countries with a total population of four billion people — more than 50% of the world's population. In terms of the number of approvals received by state regulators, this Russian drug ranks second in the world. The effectiveness of the vaccine was 97.6% based on the analysis of data from 3.8 million vaccinated Russians — this is higher than the information previously published in the medical journal The Lancet (91.6 %). Data on the use of Sputnik V during vaccination of the population in some countries demonstrate that the development is one of the safest and most effective against coronavirus, RDIF reported. Vaccination remains the most reliable way to protect against coronavirus. According to the head of the Russian Ministry of Health Mikhail Murashko, the share of vaccinated among seriously ill COVID-19 is less than 0.03 percent, while the vast majority of patients in hospitals are unvaccinated. At the end of September, the WHO announced the association of deaths from SARS-CoV-2 with the refusal of preventive immunization.
